ALGN

Align Technology, maker of the Invisalign tooth-straightening system, is positioned to potentially beat earnings estimates in its upcoming October 28, 2026 report. The company has a strong track record of beating estimates with an average surprise of 8.64% over the past two quarters. With a positive Earnings ESP of +1.23% combined with a Zacks Rank #3 (Hold), analysts suggest another earnings beat is likely, as stocks with this combination historically beat consensus estimates nearly 70% of the time.

The article highlights two medical stocks with positive Earnings Surprise Prediction (ESP) metrics that could outperform expectations: Align Technology (ALGN) with a +1.23% ESP ahead of October 28 earnings, and Iovance Biotherapeutics (IOVA) with a +22.22% ESP before November 5 earnings. Both stocks hold a Zacks Rank #3 (Hold) rating, and positive ESP combined with favorable rankings historically produce positive surprises 70% of the time.